Intralipid for Repeated Implantation Failure

• Status: Completed
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

Intralipid infusion can improve outcome in women with recurrent Intracytoplasmic sperm injection ( ICSI) failure due to elevated TH1 cytokine response.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cairo University
• Treatments: Soybean oil, phospholipid emulsion

Criteria

Inclusion Criteria:

• Infertile patients undergoing ICSI cycle with history of repeated implantation failure

Exclusion Criteria:

1. Disturbances of normal fat metabolism such as pathologic hyperlipemia

2. Allergic to it; or to eggs, soybean oil, or safflower oil.

3. Severe liver disease, kidney disease, lung disease, anemia, blood clotting disorder.

4. Uterine fibroid, endometrial polyp, endometriosis and hydrosalpinx.